Literature DB >> 23008308

Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.

Tim A Ahles1, James C Root, Elizabeth L Ryan.   

Abstract

Cognitive changes associated with cancer and cancer treatments have become an increasing concern. Using breast cancer as the prototype, we reviewed the research from neuropsychological, imaging, genetic, and animal studies that have examined pre- and post-treatment cognitive change. An impressive body of research supports the contention that a subgroup of patients is vulnerable to post-treatment cognitive problems. We also propose that models of aging may be a useful conceptual framework for guiding research in this area and suggest that a useful perspective may be viewing cognitive change in patients with cancer within the context of factors that influence the trajectory of normal aging.

Entities:  

Mesh:

Year:  2012        PMID: 23008308      PMCID: PMC3675678          DOI: 10.1200/JCO.2012.43.0116

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  75 in total

1.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.

Authors:  Sabine Deprez; Frederic Amant; Refika Yigit; Kathleen Porke; Judith Verhoeven; Jan Van den Stock; Ann Smeets; Marie-Rose Christiaens; Alexander Leemans; Wim Van Hecke; Joris Vandenberghe; Mathieu Vandenbulcke; Stefan Sunaert
Journal:  Hum Brain Mapp       Date:  2011-03       Impact factor: 5.038

3.  No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors.

Authors:  Eisho Yoshikawa; Yutaka Matsuoka; Masatoshi Inagaki; Tomohito Nakano; Tatsuo Akechi; Makoto Kobayakawa; Maiko Fujimori; Naoki Nakaya; Nobuya Akizuki; Shigeru Imoto; Koji Murakami; Yosuke Uchitomi
Journal:  Breast Cancer Res Treat       Date:  2005-07       Impact factor: 4.872

4.  Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy.

Authors:  Vincent Koppelmans; Michiel B de Ruiter; Fedde van der Lijn; Willem Boogerd; Caroline Seynaeve; Aad van der Lugt; Henri Vrooman; Wiro J Niessen; Monique M B Breteler; Sanne B Schagen
Journal:  Breast Cancer Res Treat       Date:  2011-12-29       Impact factor: 4.872

5.  Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.

Authors:  Sanne B Schagen; Martin J Muller; Willem Boogerd; Gideon J Mellenbergh; Frits S A M van Dam
Journal:  J Natl Cancer Inst       Date:  2006-12-06       Impact factor: 13.506

6.  Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.

Authors:  Christina A Meyers; Maher Albitar; Elihu Estey
Journal:  Cancer       Date:  2005-08-15       Impact factor: 6.860

7.  Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy.

Authors:  Masatoshi Inagaki; Eisho Yoshikawa; Yutaka Matsuoka; Yuriko Sugawara; Tomohito Nakano; Tatsuo Akechi; Noriaki Wada; Shigeru Imoto; Koji Murakami; Yosuke Uchitomi
Journal:  Cancer       Date:  2007-01-01       Impact factor: 6.860

8.  Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  Breast Cancer Res Treat       Date:  2010-08-06       Impact factor: 4.872

9.  Predictors of cognitive decline after chemotherapy in breast cancer patients.

Authors:  Katharine J Vearncombe; Margaret Rolfe; Margaret Wright; Nancy A Pachana; Brooke Andrew; Geoffrey Beadle
Journal:  J Int Neuropsychol Soc       Date:  2009-08-27       Impact factor: 2.892

10.  Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy.

Authors:  Torricia H Yamada; Natalie L Denburg; Leigh J Beglinger; Susan K Schultz
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

View more
  227 in total

1.  Impact of increasing physical activity on cognitive functioning in breast cancer survivors: Rationale and study design of Memory & Motion.

Authors:  Sheri J Hartman; Loki Natarajan; Barton W Palmer; Barbara Parker; Ruth E Patterson; Dorothy D Sears
Journal:  Contemp Clin Trials       Date:  2015-09-30       Impact factor: 2.226

Review 2.  Cognitive and Affective Symptoms Experienced by Cancer Patients Receiving High-Dose Intravenous Interleukin 2 Therapy: An Integrative Literature Review.

Authors:  Tara K Mann; Robin B Dail; Donald E Bailey
Journal:  Cancer Nurs       Date:  2016 Sep-Oct       Impact factor: 2.592

3.  Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient's assessment of own functioning inventory.

Authors:  Kathleen Van Dyk; Patricia A Ganz; Linda Ercoli; Laura Petersen; Catherine M Crespi
Journal:  Support Care Cancer       Date:  2016-07-19       Impact factor: 3.603

4.  Association of cancer and Alzheimer's disease risk in a national cohort of veterans.

Authors:  Laura Frain; David Swanson; Kelly Cho; David Gagnon; Kun Ping Lu; Rebecca A Betensky; Jane Driver
Journal:  Alzheimers Dement       Date:  2017-07-12       Impact factor: 21.566

Review 5.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.

Authors:  Mackenzi Pergolotti; Nicolò Matteo Luca Battisti; Lynne Padgett; Alix G Sleight; Maya Abdallah; Robin Newman; Kathleen Van Dyk; Kelley R Covington; Grant R Williams; Frederiek van den Bos; YaoYao Pollock; Elizabeth A Salerno; Allison Magnuson; Isabella F Gattás-Vernaglia; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2019-10-14       Impact factor: 3.599

6.  Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Authors:  Andrew J Saykin; Michiel B de Ruiter; Brenna C McDonald; Sabine Deprez; Daniel H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

Review 7.  Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction.

Authors:  DeeDee Smart
Journal:  Semin Radiat Oncol       Date:  2017-10       Impact factor: 5.934

8.  A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients.

Authors:  D D Correa; J C Root; R Baser; D Moore; K K Peck; E Lis; T B Shore; H T Thaler; A Jakubowski; N Relkin
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

9.  Quality of life (QOL) and symptom burden (SB) in patients with breast cancer.

Authors:  Julia Hamer; Rachel McDonald; Liying Zhang; Sunil Verma; Angela Leahey; Christine Ecclestone; Gillian Bedard; Natalie Pulenzas; Anchal Bhatia; Ronald Chow; Carlo DeAngelis; Janet Ellis; Eileen Rakovitch; Justin Lee; Edward Chow
Journal:  Support Care Cancer       Date:  2016-09-30       Impact factor: 3.603

Review 10.  Disease drivers of aging.

Authors:  Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt
Journal:  Ann N Y Acad Sci       Date:  2016-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.